The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.

Entos Pharmaceuticals has announced an investment of C$62m ($43.05m) from the governments of Canada and Alberta for an R&D facility.

WuXi XDC Cayman has signed a memorandum of understanding (MoU) with South Korea-based AbTis to advance next-generation ADCs.

The deal comes after a challenging few years for 2seventy bio, which had divested research programmes in recent years.

Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...

MSD has opened a $1bn facility in Durham located in the US state of North Carolina, to increase vaccine manufacturing ...

Lundbeck has gained ODD from Japan’s Ministry of Health, Labor and Welfare (MHLW) for amlenetug to treat multiple system ...

AWS’s framework will speed up the analysis of ElevateBio’s large protein datasets, hinting at promising drug candidates.

The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe ...

There is no excerpt because this is a protected post.

Kenox and Lactiga US have announced a strategic partnership for progressing new mucosal-targeted sIgA therapies development.

The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.